Aqua Fine Injecta Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 0.81 M
- Company Age 35 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.60 M
- Satisfied Charges ₹ 3.67 Cr
- Revenue Growth -11.40%
- Profit Growth -16.82%
- Ebitda -32.31%
- Net Worth 155.37%
- Total Assets 21.65%
About Aqua Fine Injecta
Aqua Fine Injecta Pvt Ltd (AFIPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 April 1989 and has a history of 35 years and nine months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.81 M.
The company currently has active open charges totaling ₹1.60 M. The company has closed loans amounting to ₹3.67 Cr, as per Ministry of Corporate Affairs (MCA) records.
Dilip Gujar and Neeta Gujar serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U28999MH1989PTC051419
-
Company No.
051419
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Apr 1989
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
What products or services does Aqua Fine Injecta Pvt Ltd offer?
Aqua Fine Injecta Pvt Ltd offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement.
Who are the key members and board of directors at Aqua Fine Injecta?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dilip Gujar
|
Director | 19-Apr-1989 | Current |
|
Neeta Gujar
|
Director | 30-Aug-2020 | Current |
Financial Performance of Aqua Fine Injecta.
Aqua Fine Injecta Pvt Ltd, for the financial year ended 2021, experienced significant reduction in revenue, with a 11.4% decrease. The company also saw a substantial fall in profitability, with a 16.82% decrease in profit. The company's net worth Soared by an impressive increase of 155.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aqua Fine Injecta?
In 2020, Aqua Fine Injecta had a promoter holding of 82.72% and a public holding of 17.28%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.60 M
₹36.70 M
Charges Breakdown by Lending Institutions
- Others : 0.16 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jun 2024 | Others | ₹0.80 M | Open |
| 18 Apr 2023 | Others | ₹0.80 M | Open |
| 19 Jun 2019 | Others | ₹1.70 M | Satisfied |
| 02 May 2005 | Janseva Sahakari Bank Limited | ₹1.50 M | Satisfied |
| 02 May 2005 | Janseva Sahakari Bank Limited | ₹8.50 M | Satisfied |
How Many Employees Work at Aqua Fine Injecta?
Unlock and access historical data on people associated with Aqua Fine Injecta, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aqua Fine Injecta, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aqua Fine Injecta's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
